1E7-03
CAS No. 1565845-92-2
1E7-03 ( 1E703; 1E7 03; 1E7-03 )
Catalog No. M12234 CAS No. 1565845-92-2
1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1E7-03
-
NoteResearch use only, not for human use.
-
Brief Description1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM).
-
Description1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM); disrupts the interaction of Tat with PP1, inhibits HIV-1 transcription with IC50 of 2 uM, with no cytotoxicity and displays a plasma half-life greater than 8 h in mice; inhibits EBOV transcription and strongly induces VP30 phosphorylation in the N-terminal Ser residues 29-46.
-
Synonyms1E703; 1E7 03; 1E7-03
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1565845-92-2
-
Formula Weight503.56
-
Molecular FormulaC28H29N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C(CC/C2=C\C3=CC=C(OC)C(OC)=C3)C2=NC4=CC=CC=C14)OC(C)C(NC(NCC)=O)=O
-
Chemical Name1-(3-ethylureido)-1-oxopropan-2-yl (Z)-3-(3,4-dimethoxybenzylidene)-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carey BD, et al. J Virol. 2018 May 16. pii: JVI.02068-17.
2. Ilinykh PA, et al. J Biol Chem. 2014 Aug 15;289(33):22723-38.
3. Ammosova T, et al. Br J Pharmacol. 2014 Nov;171(22):5059-75.
4. Lin X, et al. Oncotarget. 2017 Aug 7;8(44):76749-76769.
2. Ilinykh PA, et al. J Biol Chem. 2014 Aug 15;289(33):22723-38.
3. Ammosova T, et al. Br J Pharmacol. 2014 Nov;171(22):5059-75.
4. Lin X, et al. Oncotarget. 2017 Aug 7;8(44):76749-76769.
molnova catalog
related products
-
PF-4776548
PF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
Amprenavir
A potent HIV-1 protease inhibitor with IC50 of 80 nM, has mean IC50 of 12 nM against 6 HIV clinical isolates.
-
Dolutegravir
Dolutegravir (GSK1349572) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM.